Actively Recruiting
Mesenchymal Stem Cells in the Treatment of Burn Wounds
Led by The First Affiliated Hospital of Xinxiang Medical College · Updated on 2026-05-12
90
Participants Needed
1
Research Sites
139 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Burn patients were randomly divided into the low-dose stem cell gel group, the high-dose stem cell gel group, and the placebo group (with only the gel), and received the same treatment under the same conditions simultaneously.
CONDITIONS
Official Title
Mesenchymal Stem Cells in the Treatment of Burn Wounds
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Voluntary participation and signing of the informed consent form
- Burn patients requiring autologous skin grafting
- Age between 18 and 65 years, any gender
- Single donor skin area treatment on lateral thigh or trunk during study
- Skin burn area less than 30% of total body surface area
- First-time donor of medium-thick skin (~0.4mm thickness)
- Excised skin flap area at least 90 cm2
- Able to follow study protocol and attend regular postoperative follow-up visits
You will not qualify if you...
- Allergy to sodium alginate (gel component)
- Electric shock injuries, chemical burns, radiation injuries, or other combined traumas
- Severe systemic diseases as judged by researchers
- Uncontrolled hypertension or diabetes as judged by researchers
- Pregnant or lactating women
- Conditions or treatments that may affect study assessment or efficacy evaluation
- Acute or chronic kidney disease, renal failure, or elevated serum creatinine
- Acute or chronic liver disease or elevated liver enzymes
- History of malignant tumors
- Participation in other clinical studies within the last 3 months
- Mental disorders impairing self-awareness or clear communication
- Use of immunosuppressants or long-term corticosteroids (over 1 month), excluding local use
- Infectious diseases with any positive test among four items
- Other severe systemic diseases
- Other conditions deemed ineligible by researchers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The First Affiliated Hospital of Xinxiang Medical College
Xinxiang, Henan, China, 453000
Actively Recruiting
Research Team
W
Wenjie Ren
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here